Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 60601-60650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04005339
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer
PHASE2Recruiting
50 participants
Started: Jul 29, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors4 locations
NCT03841617
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
PHASE2Recruiting
30 participants
Started: Jul 29, 2019 · Completed: Nov 1, 2035
1 condition1 sponsor1 location
NCT05373810
Registration Study Sarcoma
N/ARecruiting
1,000 participants
Started: Jul 29, 2019 · Completed: Apr 2, 2029
1 condition2 sponsors2 locations
NCT04685746
BALANCED GROWTH: The Involvement of the Vestibular System in a Child's Cognitive and Motor Development
N/ARecruiting
250 participants
Started: Jul 29, 2019 · Completed: Oct 31, 2028
2 conditions2 sponsors1 location
NCT04042155
Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)
N/ARecruiting
1,600 participants
Started: Jul 29, 2019 · Completed: Aug 31, 2024
2 conditions2 sponsors1 location
NCT04030507
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NARecruiting
214 participants
Started: Jul 26, 2019 · Completed: Feb 28, 2026
6 conditions2 sponsors1 location
NCT04042857
Safety and Efficacy of Next Science Gel on Toenail Fungus
NARecruiting
20 participants
Started: Jul 26, 2019 · Completed: Oct 1, 2021
1 condition4 sponsors1 location
NCT04543253
Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)
N/ARecruiting
700 participants
Started: Jul 25, 2019 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04064359
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
PHASE1Recruiting
200 participants
Started: Jul 25, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor27 locations
NCT03821129
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
NARecruiting
636 participants
Started: Jul 25, 2019 · Completed: Oct 31, 2031
2 conditions1 sponsor44 locations
NCT03999229
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
PHASE1Recruiting
35 participants
Started: Jul 25, 2019 · Completed: Feb 29, 2028
1 condition3 sponsors1 location
NCT04184687
The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction
NARecruiting
88 participants
Started: Jul 25, 2019 · Completed: Jul 25, 2027
2 conditions1 sponsor1 location
NCT03876223
Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
N/ARecruiting
180 participants
Started: Jul 24, 2019 · Completed: Feb 28, 2026
2 conditions2 sponsors2 locations
NCT03884075
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
PHASE2Recruiting
84 participants
Started: Jul 24, 2019 · Completed: Oct 2, 2026
2 conditions2 sponsors1 location
NCT03534947
A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
PHASE2Recruiting
20 participants
Started: Jul 23, 2019 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT04344899
Pediatric Oncology Recovery Trial After Surgery
N/ARecruiting
288 participants
Started: Jul 23, 2019 · Completed: Jan 31, 2028
1 condition1 sponsor3 locations
NCT03957382
Evaluation of Safety and Efficacy of the Accero® (Heal) Stent for Intracranial Aneurysm Treatment
N/ARecruiting
130 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT04758325
The Sarcoma Biology and Outcome Project
N/ARecruiting
3,000 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2032
3 conditions1 sponsor1 location
NCT04034264
Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing
N/ARecruiting
6,500 participants
Started: Jul 23, 2019 · Completed: Jul 1, 2026
2 conditions1 sponsor6 locations
NCT04014829
Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy
N/ARecruiting
436 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT04212910
Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
N/ARecruiting
101 participants
Started: Jul 23, 2019 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT03899337
A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome
PHASE2Recruiting
105 participants
Started: Jul 23, 2019 · Completed: May 31, 2027
1 condition3 sponsors16 locations
NCT03610802
Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies
N/ARecruiting
3,000 participants
Started: Jul 22, 2019 · Completed: Mar 31, 2038
1 condition1 sponsor3 locations
NCT03935139
Monitoring of the Bone Free Flaps With Microdialysis
NARecruiting
40 participants
Started: Jul 22, 2019 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT04110522
Psoriatic Arthritis D2P Screening
NARecruiting
18,000 participants
Started: Jul 22, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT03968679
Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer
NARecruiting
90 participants
Started: Jul 22, 2019 · Completed: Jul 1, 2028
1 condition2 sponsors1 location
NCT04981184
Informative of Surface Electromyography and Prognostic Factors in Assessing the Recovery of Balance and Gait After Stroke
NARecruiting
100 participants
Started: Jul 22, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT03667326
Postpartum Low-Dose Aspirin and Preeclampsia
PHASE2Recruiting
100 participants
Started: Jul 22, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04104464
Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
N/ARecruiting
200 participants
Started: Jul 22, 2019 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT04025944
Real World Study of Chronic Viral Hepatitis
N/ARecruiting
10,000 participants
Started: Jul 20, 2019 · Completed: Aug 1, 2029
1 condition1 sponsor1 location
NCT06452745
Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile
N/ARecruiting
2,000 participants
Started: Jul 20, 2019 · Completed: Jun 30, 2040
4 conditions1 sponsor2 locations
NCT04149691
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
PHASE1Recruiting
42 participants
Started: Jul 19, 2019 · Completed: Jun 30, 2024
7 conditions2 sponsors7 locations
NCT03897881
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
PHASE2Recruiting
267 participants
Started: Jul 18, 2019 · Completed: Sep 9, 2029
1 condition2 sponsors22 locations
NCT04463160
Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island.
NARecruiting
2,000 participants
Started: Jul 18, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03936647
The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices
NARecruiting
250 participants
Started: Jul 18, 2019 · Completed: Jan 31, 2026
5 conditions1 sponsor4 locations
NCT04004169
Closed-Loop Deep Brain Stimulation for Major Depression
NARecruiting
12 participants
Started: Jul 18, 2019 · Completed: Jun 28, 2035
1 condition1 sponsor1 location
NCT04079270
The Breast Cancer Personalized Nutrition Study
NARecruiting
200 participants
Started: Jul 17, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04062292
Gait Parameters and Balance in Patients With Obstructive Lung Diseases
N/ARecruiting
30 participants
Started: Jul 17, 2019 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT02926729
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
NARecruiting
98 participants
Started: Jul 17, 2019 · Completed: Aug 31, 2025
1 condition3 sponsors1 location
NCT04030676
QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis
NARecruiting
196 participants
Started: Jul 17, 2019 · Completed: Apr 30, 2026
1 condition1 sponsor2 locations
NCT06332183
GWAS and EWAS in Patients With Erdheim-Chester Disease
N/ARecruiting
300 participants
Started: Jul 17, 2019 · Completed: Oct 1, 2024
1 condition1 sponsor5 locations
NCT03492671
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
PHASE2Recruiting
30 participants
Started: Jul 17, 2019 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT04899154
Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With Biotherapy
NARecruiting
80 participants
Started: Jul 16, 2019 · Completed: May 15, 2026
1 condition1 sponsor1 location
NCT03907475
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
PHASE2Recruiting
115 participants
Started: Jul 16, 2019 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT03662373
Innovative SolutIons for DosimEtry in Hadrontherapy (INSIDE)
N/ARecruiting
40 participants
Started: Jul 16, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04033224
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
N/ARecruiting
1,000 participants
Started: Jul 16, 2019 · Completed: Sep 30, 2025
4 conditions2 sponsors15 locations
NCT04087902
Long-Term Longitudinal QoL in Patients Undergoing EEA
N/ARecruiting
400 participants
Started: Jul 16, 2019 · Completed: Dec 31, 2025
8 conditions1 sponsor1 location
NCT03816345
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
PHASE1Recruiting
300 participants
Started: Jul 16, 2019 · Completed: Mar 30, 2028
14 conditions1 sponsor52 locations
NCT03899350
The Influencing Factors and Prediction Model of Poor Prognosis of Spontaneous Intraparenchymal Hemorrhage
N/ARecruiting
1,000 participants
Started: Jul 15, 2019 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT03989323
A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE
N/ARecruiting
2,000 participants
Started: Jul 15, 2019 · Completed: Jul 15, 2029
1 condition1 sponsor5 locations